These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19360146)

  • 1. Targeting SRC and epidermal growth factor receptor in colorectal cancer: rationale and progress into the clinic.
    Kopetz S
    Gastrointest Cancer Res; 2007; 1(4 Suppl 2):S37-41. PubMed ID: 19360146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells.
    Xu KP; Yin J; Yu FS
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2832-9. PubMed ID: 16799022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells.
    Thibault B; Jean-Claude B
    J Ovarian Res; 2017 Apr; 10(1):31. PubMed ID: 28446239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dasatinib is synergistic with cetuximab and cisplatin in triple-negative breast cancer cells.
    Kim EM; Mueller K; Gartner E; Boerner J
    J Surg Res; 2013 Nov; 185(1):231-9. PubMed ID: 23899511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
    Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
    J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.
    Buchanan FG; Gorden DL; Matta P; Shi Q; Matrisian LM; DuBois RN
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1492-7. PubMed ID: 16432186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
    Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
    Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors.
    Damiano V; Caputo R; Bianco R; D'Armiento FP; Leonardi A; De Placido S; Bianco AR; Agrawal S; Ciardiello F; Tortora G
    Clin Cancer Res; 2006 Jan; 12(2):577-83. PubMed ID: 16428503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant signal transducer and activator of transcription 3 and epidermal growth factor receptor or Src.
    Jaganathan S; Yue P; Turkson J
    J Pharmacol Exp Ther; 2010 May; 333(2):373-81. PubMed ID: 20100905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential.
    Mao W; Irby R; Coppola D; Fu L; Wloch M; Turner J; Yu H; Garcia R; Jove R; Yeatman TJ
    Oncogene; 1997 Dec; 15(25):3083-90. PubMed ID: 9444956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
    Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
    Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
    Harding J; Burtness B
    Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular rationale of Src inhibition in colorectal carcinomas.
    Gargalionis AN; Karamouzis MV; Papavassiliou AG
    Int J Cancer; 2014 May; 134(9):2019-29. PubMed ID: 23733480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
    Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
    Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular Ca2+, PYK-2, and p60(src).
    Keely SJ; Calandrella SO; Barrett KE
    J Biol Chem; 2000 Apr; 275(17):12619-25. PubMed ID: 10777553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capacitative calcium entry contributes to the differential transactivation of the epidermal growth factor receptor in response to thiazolidinediones.
    Dewar BJ; Gardner OS; Chen CS; Earp HS; Samet JM; Graves LM
    Mol Pharmacol; 2007 Nov; 72(5):1146-56. PubMed ID: 17686966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer.
    Wu W; Yang Q; Fung KM; Humphreys MR; Brame LS; Cao A; Fang YT; Shih PT; Kropp BP; Lin HK
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):69-79. PubMed ID: 24296312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
    Mueller KL; Hunter LA; Ethier SP; Boerner JL
    Cancer Res; 2008 May; 68(9):3314-22. PubMed ID: 18451158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12/SDF-1α induces migration via SRC-mediated CXCR4-EGFR cross-talk in gastric cancer cells.
    Cheng Y; Qu J; Che X; Xu L; Song N; Ma Y; Gong J; Qu X; Liu Y
    Oncol Lett; 2017 Aug; 14(2):2103-2110. PubMed ID: 28781651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.